[Early hearning screening by otoacoustic emissions and auditory brain stem response in Nabeul]

La Tunisie Medicale
|December 18, 2013
PubMed

Insights

This study screened 397 infants for hearing loss using evoked otoacoustic emissions (EOAE) and auditory brainstem response (ABR). A 1.76% prevalence was found, with correlations to bacterial meningitis and trisomy 21.

Area of Science:

  • Pediatrics
  • Audiology
  • Genetics

Context:

  • Congenital hearing loss is a common birth defect, affecting 1-3 per 1000 live births.
  • Early detection is crucial for speech, language, and cognitive development.
  • Infants with identified risk factors require timely audiological assessment.

Purpose:

  • To determine the frequency of deafness in newborns and infants under six months.
  • To identify correlations between hearing loss and Joint Committee on Infant Screening risk factors.
  • To evaluate the efficacy of a two-stage screening strategy.

Summary:

  • A two-stage screening using evoked otoacoustic emissions (EOAE) and auditory brainstem response (ABR) was performed on 397 at-risk infants.
  • EOAE identified 9.32% positive cases, with ABR confirming 1.76% prevalence of hearing loss.
  • Significant correlations were found with bacterial meningitis and trisomy 21, though 40% were lost to follow-up.

Impact:

  • Evoked otoacoustic emissions (EOAE) combined with auditory brainstem response (ABR) offer an effective hearing loss screening method.
  • Establishing robust follow-up networks is essential for successful infant hearing screening programs.
  • This research highlights the importance of integrating audiological screening into neonatal care pathways.
Abstract

Related Concept Videos